Johnson & Johnson ends talks to buy Actelion

Johnson & Johnson ends talks to buy Actelion


The New Brunswick, New Jersey-based health care giant said Tuesday it was unable to reach a deal that would have created "adequate value" for its shareholders. Johnson & Johnson develops drugs and makes medical devices and other consumer products.



from Biotech News